Stericycle
Market Cap
US$4.9b
Last Updated
2019/10/21 23:43 UTC
Data Sources
Company Financials +
Executive Summary
Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally.
Snowflake
Fundamentals
Overvalued with worrying balance sheet.
Similar Companies
Share Price & News
How has Stericycle's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
6.2%
SRCL
1.8%
US Commercial Services
0.5%
US Market
1 Year Return
3.5%
SRCL
18.7%
US Commercial Services
6.8%
US Market
Return vs Industry: SRCL underperformed the US Commercial Services industry which returned 18.7% over the past year.
Return vs Market: SRCL underperformed the US Market which returned 6.8% over the past year.
Shareholder returns
| SRCL | Industry | Market | |
|---|---|---|---|
| 7 Day | 6.2% | 1.8% | 0.5% |
| 30 Day | 7.2% | 2.5% | -0.8% |
| 90 Day | 15.8% | 2.6% | -0.9% |
| 1 Year | 3.5%3.5% | 23.1%18.7% | 9.2%6.8% |
| 3 Year | -27.5%-27.5% | 73.5%61.6% | 45.6%36.2% |
| 5 Year | -56.2%-56.2% | 104.1%83.6% | 63.2%45.4% |
Price Volatility Vs. Market
How volatile is Stericycle's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 days ago | Simply Wall St
What Kind Of Share Price Volatility Should You Expect For Stericycle, Inc. (NASDAQ:SRCL)?3 weeks ago | Simply Wall St
Introducing Stericycle (NASDAQ:SRCL), The Stock That Slid 57% In The Last Five Years1 month ago | Simply Wall St
Is There An Opportunity With Stericycle, Inc.'s (NASDAQ:SRCL) 38% Undervaluation?Valuation
Is Stericycle undervalued compared to its fair value and its price relative to the market?
29.0%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: SRCL ($53.96) is trading below our estimate of fair value ($76.01)
Significantly Below Fair Value: SRCL is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: SRCL is unprofitable, so we can't compare its PE Ratio to the Commercial Services industry average.
PE vs Market: SRCL is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SRCL's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SRCL is overvalued based on its PB Ratio (1.9x) compared to the US Commercial Services industry average (1.8x).
Next Steps
Future Growth
How is Stericycle forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
125.8%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SRCL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SRCL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SRCL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SRCL's revenue (3.5% per year) is forecast to grow slower than the US market (7.2% per year).
High Growth Revenue: SRCL's revenue (3.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SRCL's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has Stericycle performed over the past 5 years?
-55.0%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: SRCL is unprofitable, and losses have increased over the past 5 years at a rate of -55% per year.
Accelerating Growth: Unable to compare SRCL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SRCL is unprofitable, making it difficult to compare its past year earnings growth to the Commercial Services industry (-2.4%).
Return on Equity
High ROE: SRCL has a negative Return on Equity (-14.19%), as it is currently unprofitable.
Return on Assets
ROA vs Industry: SRCL is currently unprofitable, so its Return on Assets is negative.
Return on Capital Employed
ROCE Improving: SRCL is currently unprofitable, so its Return on Capital Employed is negative.
Next Steps
Financial Health
How is Stericycle's financial position?
Financial Position Analysis
Short Term Liabilities: SRCL's short term assets ($819.1M) exceeds its short term liabilities ($784.2M)
Long Term Liabilities: SRCL's short term assets (819.1M) do not cover its long term liabilities (3.5B)
Debt to Equity History and Analysis
Debt Level: SRCL's debt to equity ratio (109.9%) is considered high
Reducing Debt: SRCL's debt to equity ratio has increased from 92.6% to 109.9% over the past 5 years.
Debt Coverage: SRCL's debt is not well covered by operating cash flow (0.2%).
Interest Coverage: SRCL is unprofitable, therefore interest payments are not well covered by earnings.
Balance Sheet
Inventory Level: SRCL has a low level of unsold assets or inventory.
Debt Coverage by Assets: SRCL's debt is not covered by short term assets (assets are 0.3x debt).
Next Steps
Dividend
What is Stericycle's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: Unable to evaluate SRCL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate SRCL's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if SRCL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SRCL's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SRCL's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of Stericycle's salary, the management and board of directors tenure and is there insider trading?
0.8yrs
Average management tenure
CEO
Cindy Miller (56yo)
0.4yrs
Tenure
US$2,375,730
Compensation
Ms. Cindy J. Miller has been the President of Stericycle, Inc. since October 1, 2018, Chief Executive Officer since May 2, 2019 and as its Director since February 28, 2019. Ms. Miller served as Chief Opera ...
CEO Compensation Analysis
Compensation vs. Market: Cindy has recently become CEO, making it difficult to compare their total compensation against companies of similar size in the US market.
Compensation vs Earnings: Insufficient data to compare Cindy's compensation with company performance.
Management Age and Tenure
0.8yrs
Average Tenure
56yo
Average Age
Experienced Management: SRCL's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Age and Tenure
1.5yrs
Average Tenure
64yo
Average Age
Experienced Board: SRCL's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Management Team
Rich Hoffman (52yo)
Senior VP & Chief Accounting Officer
- Tenure: 2.4yrs
Kurt Rogers (47yo)
Executive VP
- Tenure: 2.3yrs
- Compensation: US$1.00m
David Stahl (54yo)
Executive VP & Chief Information Officer
- Tenure: 1.5yrs
Dan Ginnetti (50yo)
Executive Vice President of International
- Tenure: 0.3yrs
- Compensation: US$1.73m
Janet Zelenka (60yo)
Executive VP & CFO
- Tenure: 0.3yrs
Jennifer Koenig
Vice President of Corporate Communications & Investor Relations
- Tenure: 0yrs
Michael Weisman (60yo)
Executive VP and Chief Ethics & Compliance Officer
- Tenure: 1.5yrs
Cindy Miller (56yo)
President
- Tenure: 0.4yrs
- Compensation: US$2.38m
Joe Reuter (57yo)
Executive VP & Chief People Officer
- Tenure: 0.8yrs
Richard Moore (57yo)
Executive Vice President of North American Operations
- Tenure: 0.8yrs
Board Members
Mike Zafirovski (65yo)
Director
- Tenure: 6.9yrs
- Compensation: US$185.00k
Thomas Chen (69yo)
Director
- Tenure: 5.4yrs
- Compensation: US$185.00k
Brian Anderson (68yo)
Director
- Tenure: 2.8yrs
- Compensation: US$200.00k
Ronee Hagen (73yo)
Director
- Tenure: 1.3yrs
- Compensation: US$148.50k
Kay Priestly (63yo)
Director
- Tenure: 1.3yrs
- Compensation: US$148.50k
Bob Murley (69yo)
Chairman
- Tenure: 1.6yrs
- Compensation: US$260.00k
Steve Hooley (55yo)
Director
- Tenure: 0.6yrs
Lynn Bleil (56yo)
Director
- Tenure: 4.4yrs
- Compensation: US$191.25k
J. Hackney (49yo)
Director
- Tenure: 0.6yrs
Cindy Miller (56yo)
President
- Tenure: 0.4yrs
- Compensation: US$2.38m
Company Information
Stericycle, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Stericycle, Inc.
- Ticker: SRCL
- Exchange: NasdaqGS
- Founded: 1989
- Industry: Environmental and Facilities Services
- Sector: Commercial Services
- Market Cap: US$4.917b
- Shares outstanding: 91.12m
- Website: https://www.stericycle.com
Number of Employees
Location
- Stericycle, Inc.
- 28161 North Keith Drive
- Lake Forest
- Illinois
- 60045
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| SRCL | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Aug 1996 |
| SY9 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Aug 1996 |
| 0L9O | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Aug 1996 |
Biography
Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates thro ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/21 23:43 |
| End of Day Share Price | 2019/10/21 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.